NCT00827476

Brief Summary

we will perform xenotransplantation and in vitro culture of ovarian tissue from patients undergoing ovarian cortex cryopreservation.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Jan 2009

Longer than P75 for early_phase_1

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

January 21, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 22, 2009

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2012

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2015

Completed
Last Updated

January 22, 2009

Status Verified

January 1, 2009

Enrollment Period

3 years

First QC Date

January 21, 2009

Last Update Submit

January 21, 2009

Conditions

Keywords

ovaryhumantransplantaionovarian failure

Outcome Measures

Primary Outcomes (1)

  • improving folliculogenesis and oocuyte maturation after ovarian transplantation

    2 years

Study Arms (1)

ovarian transplantation

EXPERIMENTAL

tissue will be used for xenotransplantation or in vitro culture

Procedure: ovarian transplantation

Interventions

ovarian xenotransplantation or in vitro culture

ovarian transplantation

Eligibility Criteria

Age5 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • tissue previously obtained

You may not qualify if:

  • no tissue available or no consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 21, 2009

First Posted

January 22, 2009

Study Start

January 1, 2009

Primary Completion

January 1, 2012

Study Completion

January 1, 2015

Last Updated

January 22, 2009

Record last verified: 2009-01